<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>320-LOMITAPIDE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="LOMITAPIDE" rxcui="1364479">
<ATC code="C10AX12" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="STRONG INHIBITORS OF CYP3A4" code="J02-J05" /></DRUG2>
<DESCRIPTION>Increase of the plasma concentrations of the lomitapide due to decrease of its hepatic metabolism by the inhibitor</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>320-LOMITAPIDE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="LOMITAPIDE" rxcui="1364479">
<ATC code="C10AX12" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="ST JOHNS WORT" rxcui="258326">
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of decrease of the plasma concentrations of the lomitapide</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
</INTERACTIONS>
